Multi-level immune response network in mild-moderate Chronic Obstructive Pulmonary Disease (COPD)

Abstract

Background Chronic Obstructive Pulmonary Disease (COPD) is associated with an abnormal pulmonary and systemic immune response to tobacco smoking. Yet, how do immune cells relate within and between these two biological compartments, how the pulmonary infiltrate influences the lung transcriptome, and what is the role of active smoking vs. presence of disease is unclear. Methods To investigate these questions, we simultaneously collected lung tissue and blood from 65 individuals stratified by smoking habit and presence of the disease. The immune cell composition of both tissues was assessed by flow cytometry, whole lung transcriptome was determined with Affymetrix arrays, and we used Weighted Gene Co-expression Network Analysis (WGCNA) to integrate results. Results Main results showed that: (1) current smoking and the presence of COPD were both independently associated with a reduction in the proportion of lung T cells and an increase of macrophages, specifically those expressing CD80 + CD163+; (2) changes in the proportion of infiltrating macrophages, smoking status or the level of airflow limitation were associated to different WGCNA modules, which were enriched in iron ion transport, extracellular matrix and cilium organization gene ontologies; and, (3) circulating white blood cells counts were correlated with lung macrophages and T cells. Conclusions Mild-moderated COPD lung immune infiltrate is associated with the active smoking status and presence of disease; is associated with changes in whole lung tissue transcriptome and marginally reflected in blood. Electronic supplementary material The online version of this article (10.1186/s12931-019-1105-z) contains supplementary material, which is available to authorized users.

Sonic hedgehog signalling as a potential endobronchial biomarker in COPD

“…To validate our observations, we analysed human lung gene expression on an independent cohort (GSE47460) dataset including 145 COPD subjects and 91 control subjects [20,21].…”

Cigarette Smoke Exposure and Inflammatory Signaling Increase the Expression of the SARS-CoV-2 Receptor ACE2 in the Respiratory Tract

“…To follow up on these observations, we investigated whether ACE2 expression was affected by other lung diseases and/or carcinogen exposures. Indeed, we observed increased ACE2 expression in multiple cohorts of patients with chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF) (Figures S4A-S4D) (Cruz et al, 2019;Kim et al, 2015;McDonough et al, 2019;Pardo et al, 2005). Interestingly, both COPD and IPF are strongly associated with prior cigarette exposure (Baumgartner et al, 1997;Laniado-Laborín, 2009), and COPD in particular has been identified as a risk factor for severe COVID-19 (Lippi and Henry, 2020;Zhao et al, 2020a).…”

COVID-19, an opportunity to reevaluate the correlation between long-term effects of anthropogenic pollutants on viral epidemic/pandemic events and prevalence

“…Epidemiologic studies have linked ambient particulate matter, nitrogen dioxide and other air pollutants exposure to immunologic diseases of the respiratory system (asthma and chronic obstructive pulmonary disease (COPD)), atopic diseases, allergic sensitization, eczema and polymorphisms of inflammatory cytokines via AhR-dependent mechanisms (Morgenstern et al, 2008). Furthermore, COPD has also been associated with an abnormal pulmonary and systemic immune response to tobacco smoking, although only the so-called "susceptible smokers" develop the disease (Cruz et al, 2019). Smokers and COPD patients are subpopulations with an increased risk of severe COVID-19, likely because of the enhanced airway expression of angiotensin-converting enzyme 2 (ACE2) receptor, the entry receptor for the SARS-CoV-2 virus, in lower airways (Leung et al, 2020).…”